SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-010861
Filing Date
2022-03-17
Accepted
2022-03-17 16:03:00
Documents
14
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - Q4 2021 EARNINGS RELEASE kdny-8k_20220317.htm   iXBRL 8-K 37685
2 EX-99.1 kdny-ex991_6.htm EX-99.1 357980
3 GRAPHIC gyvklckkawjo000001.jpg GRAPHIC 67035
  Complete submission text file 0001564590-22-010861.txt   636316

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20220317.xsd EX-101.SCH 5697
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20220317_lab.xml EX-101.LAB 19424
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20220317_pre.xml EX-101.PRE 11587
8 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20220317_htm.xml XML 3563
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 22748434
SIC: 2834 Pharmaceutical Preparations